Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
3.070
-0.040 (-1.29%)
At close: Aug 1, 2025, 4:00 PM
3.026
-0.044 (-1.43%)
After-hours: Aug 1, 2025, 6:42 PM EDT
Altus Power Employees
Puma Biotechnology had 172 employees as of December 31, 2024. The number of employees decreased by 13 or -7.03% compared to the previous year.
Employees
172
Change (1Y)
-13
Growth (1Y)
-7.03%
Revenue / Employee
$1,352,959
Profits / Employee
$221,320
Market Cap
152.39M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 172 | -13 | -7.03% |
Dec 31, 2023 | 185 | -7 | -3.65% |
Dec 31, 2022 | 192 | -4 | -2.04% |
Dec 31, 2021 | 196 | -71 | -26.59% |
Dec 31, 2020 | 267 | -2 | -0.74% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PBYI News
- 8 days ago - Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results - Business Wire
- 4 weeks ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Puma Biotechnology: Updated Timelines And A Resurgence In Sentiment - Seeking Alpha
- 3 months ago - Puma Biotechnology, Inc. (PBYI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Puma Biotechnology Reports First Quarter Financial Results - Business Wire
- 3 months ago - Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients - GlobeNewsWire
- 3 months ago - Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Business Wire
- 3 months ago - Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results - Business Wire